| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.29 | 2e-12 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.23 | 7e-09 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.22 | 6e-08 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-06 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-05 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-05 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0001 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.16 | 0.0002 |